ArticleScientific reports2026
Lack of evidence for cargo release of CD63-EVs into recipient cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Extracellular vesicles (EVs), including exosomes, are widely believed to mediate intercellular communication by delivering molecular cargo into the cytosol of recipient cells. However, the efficiency and mechanisms of such cargo delivery remain unclear. In this study, we investigated whether EVs bearing the canonical tetraspanin EVs marker CD63 are capable of fusing with recipient cell membranes to release their contents. Using the highly sensitive NanoBiT split luciferase system, we tracked potential fusion events between HiBiT-tagged CD63-EVs and HEK293 cells expressing cytosolic or endosome-localized LgBiT. While HiBiT and LgBiT reconstitution was readily detected when EVs carried the viral fusion protein VSV-G, no luminescence was observed with HiBiT tagged CD63-EVs in absence of VSV-G, despite their uptake or binding by recipient cells. Similarly, EVs carrying HiBiT-HSP70 failed to show evidence of cargo release. These findings demonstrate that unmodified HiBiT-CD63-EVs do not fuse with the plasma or endosomal membranes of recipient cells, suggesting that EV-mediated cargo delivery via membrane fusion is inefficient or absent under standard culture conditions. Our results challenge the prevailing view of EV function in intercellular communication and underscore the need for re-evaluation of EV cargo transfer mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.